PL2809810T3 - Układ i sposób wykrywania rna zmienionych przez raka płuca w krwi obwodowej - Google Patents
Układ i sposób wykrywania rna zmienionych przez raka płuca w krwi obwodowejInfo
- Publication number
- PL2809810T3 PL2809810T3 PL13733697T PL13733697T PL2809810T3 PL 2809810 T3 PL2809810 T3 PL 2809810T3 PL 13733697 T PL13733697 T PL 13733697T PL 13733697 T PL13733697 T PL 13733697T PL 2809810 T3 PL2809810 T3 PL 2809810T3
- Authority
- PL
- Poland
- Prior art keywords
- altered
- lung cancer
- peripheral blood
- detecting rnas
- rnas
- Prior art date
Links
- 102000040650 (ribonucleotides)n+m Human genes 0.000 title 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 title 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 title 1
- 201000005202 lung cancer Diseases 0.000 title 1
- 208000020816 lung neoplasm Diseases 0.000 title 1
- 210000005259 peripheral blood Anatomy 0.000 title 1
- 239000011886 peripheral blood Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261584097P | 2012-01-06 | 2012-01-06 | |
| PCT/US2013/020383 WO2013103889A1 (en) | 2012-01-06 | 2013-01-04 | System and method of detecting rnas altered by cancer in peripheral blood |
| EP13733697.0A EP2809810B1 (en) | 2012-01-06 | 2013-01-04 | System and method of detecting rnas altered by lung cancer in peripheral blood |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2809810T3 true PL2809810T3 (pl) | 2020-07-27 |
Family
ID=48745455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13733697T PL2809810T3 (pl) | 2012-01-06 | 2013-01-04 | Układ i sposób wykrywania rna zmienionych przez raka płuca w krwi obwodowej |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9422592B2 (pl) |
| EP (1) | EP2809810B1 (pl) |
| JP (2) | JP2015503356A (pl) |
| AU (1) | AU2013207385B2 (pl) |
| CA (1) | CA2860338C (pl) |
| DK (1) | DK2809810T3 (pl) |
| ES (1) | ES2769795T3 (pl) |
| HU (1) | HUE047739T2 (pl) |
| IL (1) | IL233163B (pl) |
| PL (1) | PL2809810T3 (pl) |
| PT (1) | PT2809810T (pl) |
| WO (1) | WO2013103889A1 (pl) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8673555B2 (en) | 2008-02-15 | 2014-03-18 | Mayo Foundation For Medical Education And Research | Detecting neoplasm |
| US8361720B2 (en) | 2010-11-15 | 2013-01-29 | Exact Sciences Corporation | Real time cleavage assay |
| EP2971179B1 (en) | 2013-03-14 | 2019-01-09 | Mayo Foundation for Medical Education and Research | Detecting neoplasm |
| US10301680B2 (en) | 2014-03-31 | 2019-05-28 | Mayo Foundation For Medical Education And Research | Detecting colorectal neoplasm |
| US10184154B2 (en) | 2014-09-26 | 2019-01-22 | Mayo Foundation For Medical Education And Research | Detecting cholangiocarcinoma |
| CA2965528A1 (en) | 2014-11-14 | 2016-05-19 | Liquid Genomics, Inc. | Use of circulating cell-free rna for diagnosis and/or monitoring cancer |
| WO2016160454A1 (en) | 2015-03-27 | 2016-10-06 | Exact Sciences Corporation | Detecting esophageal disorders |
| JP6871926B2 (ja) | 2015-08-31 | 2021-05-19 | マヨ ファウンデーション フォア メディカル エデュケーション アンド リサーチＭａｙｏ Ｆｏｕｎｄａｔｉｏｎ ｆｏｒ Ｍｅｄｉｃａｌ Ｅｄｕｃａｔｉｏｎ ａｎｄ Ｒｅｓｅａｒｃｈ | 胃の新生物を検出すること |
| CA3002196C (en) | 2015-10-30 | 2024-05-14 | Exact Sciences Development Company, Llc | Multiplex amplification detection assay and isolation and detection of dna from plasma |
| AU2017260630B2 (en) | 2016-05-05 | 2023-07-13 | Exact Sciences Corporation | Detection of lung neoplasia by analysis of methylated DNA |
| AU2018211956B2 (en) | 2017-01-27 | 2024-06-20 | Exact Sciences Corporation | Detection of colon neoplasia by analysis of methylated DNA |
| KR20200003917A (ko) * | 2017-05-10 | 2020-01-10 | 난토믹스, 엘엘씨 | 암의 검출, 예측, 및 모니터링을 위한 순환 rna(circulating rna for detection, prediction, and monitoring of cancer) |
| WO2018226971A1 (en) * | 2017-06-07 | 2018-12-13 | Cedars-Sinai Medical Center | Peptide compositions for immuno-oncology molecular imaging and targeted drug delivery |
| WO2019075251A2 (en) | 2017-10-12 | 2019-04-18 | Nantomics, Llc | CANCER SCORE FOR EVALUATION AND PREDICTION OF RESPONSE FROM BIOLOGICAL FLUIDS |
| WO2019094363A2 (en) | 2017-11-07 | 2019-05-16 | Nanthealth Labs, Inc. | Targeted cell free nucleic acid analysis |
| AU2018374176B2 (en) | 2017-11-30 | 2024-12-12 | Exact Sciences Corporation | Detecting breast cancer |
| US10648025B2 (en) | 2017-12-13 | 2020-05-12 | Exact Sciences Development Company, Llc | Multiplex amplification detection assay II |
| US11512349B2 (en) * | 2018-12-18 | 2022-11-29 | Grail, Llc | Methods for detecting disease using analysis of RNA |
| CA3127329A1 (en) | 2019-01-24 | 2020-07-30 | Mayo Foundation For Medical Education And Research | Detecting endometrial cancer |
| WO2020236939A2 (en) | 2019-05-23 | 2020-11-26 | Paradigm Diagnostics | Tissue preparation using nuclease |
| WO2021041726A1 (en) * | 2019-08-27 | 2021-03-04 | Exact Sciences Development Company, Llc | Characterizing methylated dna, rna, and proteins in subjects suspected of having lung neoplasia |
| JP7799607B2 (ja) | 2019-10-31 | 2026-01-15 | マヨ ファウンデーション フォア メディカル エデュケーション アンド リサーチ | 卵巣癌の検出 |
| EP4069645A4 (en) | 2019-12-05 | 2023-09-13 | Council Of Scientific & Industrial Research | SOLVENT-ASSISTED CAVITATION FOR WASTEWATER TREATMENT |
| CN117947165B (zh) * | 2024-01-19 | 2024-10-08 | 西安交通大学医学院第二附属医院 | PCR检测肺腺癌癌前病变人群血浆lncRNA的检测方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100236506B1 (ko) | 1990-11-29 | 2000-01-15 | 퍼킨-엘머시터스인스트루먼츠 | 폴리머라제 연쇄 반응 수행 장치 |
| AU645915B2 (en) | 1991-07-23 | 1994-01-27 | F. Hoffmann-La Roche Ag | Improvements in the in situ PCR |
| KR0171154B1 (ko) | 1995-04-29 | 1999-03-20 | 배순훈 | 특징점 기반 움직임 추정을 이용하여 비디오 신호를 부호화하는 방법 및 장치 |
| US6040139A (en) | 1995-09-19 | 2000-03-21 | Bova; G. Steven | Laser cell purification system |
| US7785842B2 (en) | 1996-03-26 | 2010-08-31 | Oncomedx, Inc. | Comparative analysis of extracellular RNA species |
| CA2250118C (en) | 1996-03-26 | 2009-09-29 | Michael S. Kopreski | Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer |
| US8043835B1 (en) | 1996-03-26 | 2011-10-25 | Oncomedx, Inc. | Methods for detecting and monitoring cancer using extracellular RNA |
| US6759217B2 (en) | 1996-03-26 | 2004-07-06 | Oncomedx, Inc. | Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer |
| US6100051A (en) | 1997-06-27 | 2000-08-08 | The United States Of America As Represented By The Department Of Health And Human Services | Method utilizing convex geometry for laser capture microdissection |
| US8163524B2 (en) | 1998-09-22 | 2012-04-24 | Oncomedx, Inc. | Comparative analysis of extracellular RNA species |
| US7767422B2 (en) | 1998-09-22 | 2010-08-03 | Oncomedx, Inc. | Detection of 5T4 RNA in plasma and serum |
| US20040085443A1 (en) | 2000-12-13 | 2004-05-06 | Kallioniemi Olli P | Method and system for processing regions of interest for objects comprising biological material |
| US7767390B2 (en) | 2001-11-20 | 2010-08-03 | Oncomedx, Inc. | Methods for evaluating drug-resistance gene expression in the cancer patient |
| AU2003214072A1 (en) * | 2002-03-07 | 2003-09-16 | Bayer Aktiengesellschaft | Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1) |
| EP1511844A2 (en) * | 2002-05-30 | 2005-03-09 | Télogéne Inc., Institut de Pharmacologie | Methods and compositions for treating neoplasia relating to hnrnp a1 and a2 nucleic acid molecules |
| US7955846B2 (en) | 2004-05-17 | 2011-06-07 | The General Hospital Corporation | Compositions comprising female germline stem cells and methods of use thereof |
| US20060051736A1 (en) | 2004-08-19 | 2006-03-09 | Applied Imaging Corp. | Paraffin-control marker |
| EP2857523A1 (en) | 2005-02-01 | 2015-04-08 | Applied Biosystems, LLC | Method for identifying a sequence in a polynucleotide |
| US7405056B2 (en) | 2005-03-02 | 2008-07-29 | Edward Lam | Tissue punch and tissue sample labeling methods and devices for microarray preparation, archiving and documentation |
| EP2484782B1 (en) | 2006-01-05 | 2015-11-18 | The Ohio State University Research Foundation | MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers |
| WO2008054828A2 (en) | 2006-11-01 | 2008-05-08 | The Ohio State University Research Foundation | Microrna expression signature for predicting survival and metastases in hepatocellular carcinoma |
| US8189882B2 (en) | 2008-01-30 | 2012-05-29 | Clarient, Inc. | Automated laser capture microdissection |
| US8880351B2 (en) | 2008-03-25 | 2014-11-04 | General Electric Company | Method and apparatus for analysis of tissue microarrays |
| EP2350320A4 (en) | 2008-11-12 | 2012-11-14 | Caris Life Sciences Luxembourg Holdings | METHOD AND SYSTEMS FOR USE OF EXOSOMES FOR THE DETERMINATION OF PHENOTYPES |
| US8765383B2 (en) * | 2009-04-07 | 2014-07-01 | Genomic Health, Inc. | Methods of predicting cancer risk using gene expression in premalignant tissue |
| WO2010123124A1 (ja) * | 2009-04-24 | 2010-10-28 | 国立大学法人九州大学 | 固形がんの再発および予後因子、およびその臨床利用 |
-
2013
- 2013-01-04 AU AU2013207385A patent/AU2013207385B2/en active Active
- 2013-01-04 ES ES13733697T patent/ES2769795T3/es active Active
- 2013-01-04 PL PL13733697T patent/PL2809810T3/pl unknown
- 2013-01-04 US US13/734,735 patent/US9422592B2/en active Active
- 2013-01-04 CA CA2860338A patent/CA2860338C/en active Active
- 2013-01-04 EP EP13733697.0A patent/EP2809810B1/en active Active
- 2013-01-04 WO PCT/US2013/020383 patent/WO2013103889A1/en not_active Ceased
- 2013-01-04 HU HUE13733697A patent/HUE047739T2/hu unknown
- 2013-01-04 DK DK13733697.0T patent/DK2809810T3/da active
- 2013-01-04 JP JP2014551375A patent/JP2015503356A/ja active Pending
- 2013-01-04 PT PT137336970T patent/PT2809810T/pt unknown
-
2014
- 2014-06-16 IL IL233163A patent/IL233163B/en active IP Right Grant
-
2016
- 2016-07-28 US US15/222,828 patent/US20160333424A1/en not_active Abandoned
-
2019
- 2019-03-13 JP JP2019045627A patent/JP2019162102A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20130196332A1 (en) | 2013-08-01 |
| EP2809810A1 (en) | 2014-12-10 |
| IL233163A0 (en) | 2014-07-31 |
| EP2809810B1 (en) | 2019-11-13 |
| WO2013103889A1 (en) | 2013-07-11 |
| AU2013207385A1 (en) | 2014-07-10 |
| ES2769795T3 (es) | 2020-06-29 |
| US9422592B2 (en) | 2016-08-23 |
| AU2013207385B2 (en) | 2018-09-13 |
| JP2015503356A (ja) | 2015-02-02 |
| CA2860338C (en) | 2022-08-02 |
| EP2809810A4 (en) | 2015-12-02 |
| IL233163B (en) | 2019-02-28 |
| PT2809810T (pt) | 2020-02-14 |
| US20160333424A1 (en) | 2016-11-17 |
| DK2809810T3 (da) | 2020-02-03 |
| HUE047739T2 (hu) | 2020-05-28 |
| JP2019162102A (ja) | 2019-09-26 |
| CA2860338A1 (en) | 2013-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE047739T2 (hu) | Rendszer és eljárás tüdõrák által módosított RNS molekulák kimutatására perifériás vérben | |
| IL276300A (en) | GRPR antagonists for the detection, diagnosis and treatment of GRPR-positive cancer | |
| EP2695137A4 (en) | SYSTEM AND METHOD FOR DISTRIBUTED MEDICAL DETECTION | |
| PL2844146T3 (pl) | Układ i sposób pomiaru uwagi | |
| SG10201800720YA (en) | Blood treatment systems and methods | |
| EP2926328A4 (en) | SYSTEM AND METHOD FOR MEDICATION INFORMATION | |
| EP2893490A4 (en) | SYSTEM AND METHOD FOR FAST RECOVERY OF MEDICAL INFORMATION | |
| GB201120965D0 (en) | System and method for detection of analytes | |
| EP2887862A4 (en) | CLINICAL SUPPORT SYSTEM AND METHOD | |
| EP2744579A4 (en) | CONNECTED MULTIFUNCTIONAL SYSTEM AND METHOD OF USE | |
| GB201616219D0 (en) | Methods and systems for detecting biological components | |
| IL228395A0 (en) | A v-trough photobioreactor system and method for use | |
| EP2852322A4 (en) | SPIROMETER SYSTEM AND DATA ANALYSIS METHODS | |
| PL2877686T3 (pl) | Sposób i układ oczyszczania wody szczelinującej | |
| PL2929336T3 (pl) | Sposób korekty hematokrytu i przystosowany do tego glukometr | |
| AP2014007382A0 (en) | Method and system for sequencing, seeking, and displaying micro-blog | |
| EP2836267A4 (en) | TREATMENT SYSTEM AND METHOD FOR PATHOLOGICAL ELECTROMAGNETIC LESIONS | |
| EP2891465A4 (en) | MEDICAL SYSTEM AND METHOD OF OPERATION | |
| GB201115543D0 (en) | Transaction system and method | |
| EP2916483A4 (en) | TRANSACTION SYSTEM AND TRANSACTION METHOD | |
| EP2936411A4 (en) | METHOD, SYSTEM AND DEVICE FOR SALES TRANSACTIONS | |
| IL237656A0 (en) | Blood coagulation meter and method | |
| PL2529662T3 (pl) | Oftalmologiczny sposób analizy i układ do analizy | |
| EP2906310A4 (en) | GAME SYSTEM AND METHOD | |
| PL2936151T3 (pl) | Sposoby leczenia i/lub ograniczania rozwoju cukrzycy |